Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats

Vet J. 2007 Sep;174(2):425-7. doi: 10.1016/j.tvjl.2006.05.004. Epub 2006 Jun 27.

Abstract

The pharmacokinetic behavior of marbofloxacin was studied in goats after single-dose subcutaneous (SC) administration of 2mg/kg bodyweight. Drug concentration in plasma was determined by high performance liquid chromatography and the data obtained were subjected to non-compartmental kinetic analysis. Marbofloxacin peak plasma concentration (C(max)=1.77+/-0.24microg/mL) was reached 1.25+/-0.50h (T(max)) after SC administration. The elimination half-life (t(1/2beta)) and area under curve (AUC) were 5.74+/-1.21h and 8.15 vs 2.33microg h/mL, respectively. Taking into account the values obtained for the efficacy indices, it was concluded that a SC dose of 2mg/kg/24h of marbofloxacin could be adequate to treat infections caused by high susceptible bacteria like Escherichia coli or Salmonella spp.

MeSH terms

  • Animals
  • Area Under Curve
  • Chromatography, High Pressure Liquid / veterinary
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / pharmacokinetics*
  • Fluoroquinolones / administration & dosage
  • Fluoroquinolones / pharmacokinetics*
  • Goats / blood
  • Goats / metabolism*
  • Half-Life
  • Injections, Subcutaneous / veterinary
  • Quinolones / administration & dosage
  • Quinolones / pharmacokinetics*

Substances

  • Enzyme Inhibitors
  • Fluoroquinolones
  • Quinolones
  • marbofloxacin